Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01050660 · ClinicalTrials.gov registry record · NA
Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
NCT01050660 is a NA study that has completed, run by Yale University. The registered enrollment target is 136 participants.
The verdict
NCT01050660, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
Study Summary
The goal of the study is to determine if parenteral nutrition-associated cholestasis (PNAC) is related to the amount of parenteral (intravenous) fat administered to premature babies until full enteral nutrition is achieved.
Interventions
- OTHER Intravenous fat emulsion
- OTHER Restriction of intravenous fat emulsion to 1 gm/kg/d
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01050660
The ClinicalTrials.gov registry entry for NCT01050660 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intravenous fat emulsion is the first listed.
NCT01050660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01050660 about?
NCT01050660 is a clinical study titled "Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates". The goal of the study is to determine if parenteral nutrition-associated cholestasis (PNAC) is related to the amount of parenteral (intravenous) fat administered to premature babies until full enteral nutrition is achieved.
What is the current status of trial NCT01050660?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2009-06. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01050660?
The interventions under investigation include: Intravenous fat emulsion (OTHER), Restriction of intravenous fat emulsion to 1 gm/kg/d (OTHER).
Who is sponsoring clinical trial NCT01050660?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.